Recent work
Sally advises on a broad range of corporate and commercial transactions (including private acquisitions and disposals, public takeovers, joint ventures, placings, rights issues and other secondary raisings) and general advisory matters (including corporate governance, activism and takeover defence and other crisis management).
Her client base is a mix UK and US listed and large private corporates, as well as PE houses and hedge funds.
Highlights include advising:
- SEGRO on the recommended share offer by Prologis for £14bn
- SEGRO on its entry into joint ventures with Pure DC to develop a fully-fitted data centres
- Diageo on the proposed disposal of its Kenyan, Tanzanian and Ugandan listed subsidiary, East African Breweries plc to Asahi for EV $4.8bn (100%) and on the disposal of its Nigerian listed subsidiary, Guinness Nigeria, to Tolaram and its Ghanaian listed subsidiary, Guinness Ghana, to Castel
- The Restaurant Group on its recent activist campaign, the disposal of its Leisure business, its takeover by Apollo for £506mn and its disposal of its Concessions divisions to Areas
- Redrow on its all-share combination with Barrett Developments for £2.5bn
- Essentra on all elements of its strategic review, including the two Class 1 disposals of its packaging and filters divisions
- HPS Investment Partners on all of its UK investments and divestments, including, most recently, its acquisition of Falko, its acquisition of Barclays' asset finance business, and its majority investment in Nucleus, a leading investment platform provider
- Walmart on the sale of a majority stake in Asda to a consortium comprising the Issa brothers and TDR Capital for an enterprise value of £6.8bn
- William Hill on its takeover by Caesars Entertainment for £2.9bn
- IAG (the holding company for BA, Iberia and the other airlines) on its rights issue to raise up to €2.75bn
- INEOS on many of its acquisitions and disposals, including the sale of INEOS Calabrian to Ecovyst, the combination between Belstaff and Castore, its disposal of INEOS Composites to KPS for €1.7bn and its acquisition of BP's Global petrochemicals business for $5bn
- GlaxoSmithKline on its major three-part inter-conditional transaction with Novartis (in particular, on its global consumer healthcare joint venture)
Sally is recognised as a Leading Individual for M&A: Upper Mid-Market and Premium Deals: £750mn+ in Legal 500 2027 and is individually ranked in Corporate/M&A: £800mn+ in Chambers UK 2027.
"Sally is an absolute powerhouse of a lawyer and she is incredible to work with."
"Sally is terrific and easy to do a transaction with."